Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 8/20 | 0.47 |
| ▸ | ACE | P12821 | 6/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 4/20 | 0.38 |
| ▸ | MMP1 | P03956 | 2/20 | 0.37 |
| ▸ | ECE1 | P42892 | 2/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8450113 | 0.94 | MME (0.43) | MMEACECTSBMMP3 | |
| SCHEMBL8451246 | 0.93 | MME (0.47) | MMEACECTSBFDFT1MMP3 | |
| SCHEMBL8446495 | 0.93 | MME (0.43) | MMEACECTSBMMP3MMP1 | |
| SCHEMBL8453092 | 0.93 | MME (0.43) | MMEACECTSBMMP3MMP1 | |
| SCHEMBL8451272 | 0.91 | PTGES (0.39) | MMEACECTSBFDFT1MMP3 | |
| SCHEMBL8449905 | 0.91 | MME (0.52) | MMEACEFDFT1MMP3ACE2 | |
| SCHEMBL8453054 | 0.90 | MME (0.42) | MMEACECTSBMMP3ECE1 | |
| SCHEMBL8450057 | 0.89 | MME (0.40) | MMEACECTSBMMP3MMP1 | |
| SCHEMBL8453137 | 0.89 | MME (0.43) | MMEACECTSBFDFT1MMP3 | |
| SCHEMBL8451265 | 0.89 | MME (0.49) | MMEACEFDFT1MMP3ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5968980-A | ENDOPEPTIDASE 24.11 INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1999-10-19 | — | — | US | disclosed |